Eye Tech Care Secures €25M in Funding

EYE-TECH-CARE-logoEye Tech Care SA, a Lyon, France-based company developing and marketing equipment for non-invasive glaucoma treatment in ophthalmology, secured €25m in a new round of funding.

Chinese investor Everpine Capital will make the investment in two different tranches.

The company will use the funds for its international expansion benefiting from Everpine’s presence in China in order to further continue product registration begun in 2015.

Led by Dietrich Wolf, CEO of Eye Tech Care has developed EyeOP1®, a medical device which offers a non-invasive solution for treating glaucoma using ultrasound.



Join the discussion